Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 293

Results For "IMA"

3208 News Found

Fortis launches CATH LAB with 3D mapping Carto 7 machine
Hospitals | September 30, 2021

Fortis launches CATH LAB with 3D mapping Carto 7 machine

Fortis Memorial Research Institute is the only hospital in India and South Asia to acquire the machine


Wyss Center receives CE mark for Epios Cloud software
Digitisation | September 30, 2021

Wyss Center receives CE mark for Epios Cloud software

The cloud-based platform enables long-term brain monitoring towards personalized treatment


Dr Reddy’s creates world’s largest toothbrush sculpture
Events | September 29, 2021

Dr Reddy’s creates world’s largest toothbrush sculpture

Fastminar is a 40-feet structure made with approximately 80,000 toothbrushes and is located at Terna Dental College in Navi Mumbai


Lupin launches Droxidopa capsules in the US
Drug Approval | September 29, 2021

Lupin launches Droxidopa capsules in the US

Droxidopa capsules, 100 mg, 200 mg, and 300 mg is a generic equivalent of Northera capsules, 100 mg, 200 mg, and 300 mg, of Lundbeck NA


Apollo Hospitals dedicates AI tool to predict cardiovascular disease to the nation
Hospitals | September 29, 2021

Apollo Hospitals dedicates AI tool to predict cardiovascular disease to the nation

Cardiovascular disease is the leading cause of death in the Asia Pacific, and it's a problem that will only intensify as populations continue to age


MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9
Drug Approval | September 29, 2021

MSD India launches 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL 9

India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys


Eisai initiates rolling submission for Biological Licence Application of Lecanemab
Biotech | September 28, 2021

Eisai initiates rolling submission for Biological Licence Application of Lecanemab

The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology


Zebra Medical Vision receives clearance for Coronary Artery Calcium (CAC) solution
Digitisation | September 28, 2021

Zebra Medical Vision receives clearance for Coronary Artery Calcium (CAC) solution

The CAC solution cleared by the U.S. FDA analyses already existing non-gated CT scans and quantifies the coronary artery calcium in order to identify, stratify, and facilitate treatment pathways for patients with cardiovascular disease


Positive results from Lynparza with abiraterone delays Metastatic prostrate cancer
Drug Approval | September 28, 2021

Positive results from Lynparza with abiraterone delays Metastatic prostrate cancer

Prostate cancer is the second-most common cancer in men and despite an increase in the number of available treatments for men with mCRPC, five-year survival remains low


Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027
News | September 28, 2021

Cardiovascular devices market to grow at a CAGR of 3.9 % up to 2027

One of the key factors driving the market growth is the rise in the occurrence of chronic cardiovascular diseases such as heart failure and coronary artery disease: Valuates Reports